Knight Therapeutics Reports Third Quarter 2022 Results

MONTREAL, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or "the Company"), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial

Related Keywords

Mexico ,United States ,Argentina ,Brazil ,Montreal ,Quebec ,Canada ,Chile ,Colombia ,Peru ,Toronto ,Ontario ,Argentine ,America ,Canadian ,American ,Samira Sakhia ,Arvind Utchanah ,Biotoscana Farma ,Company Argentine ,Toronto Stock Exchange ,Knight Therapeutics Inc ,Latin America ,Chief Executive Officer ,Knight Therapeutics ,Settlement Agreement ,Forward Looking Statements ,Call Notice ,Toll Free ,Therapeutics Inc ,Latin American ,United Medical ,Annual Report ,Annual Information Form ,Financial Reporting ,Hyperinflation Economies ,Argentine Peso ,Normal Course Issuer ,Knight ,Herapeutics ,Reports ,Third ,Quarter ,022 ,Results ,